As of 2025-07-14, the EV/EBITDA ratio of Precision BioSciences Inc (DTIL) is 0.24. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DTIL's latest enterprise value is -5.54 mil USD. DTIL's TTM EBITDA according to its financial statements is -23.39 mil USD. Dividing these 2 quantities gives us the above DTIL EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.1x - 13.3x | 10.7x |
| Forward P/E multiples | 12.3x - 20.5x | 16.4x |
| Fair Price | (12.14) - 9.28 | (4.60) |
| Upside | -372.7% - 108.5% | -203.4% |
| Date | EV/EBITDA |
| 2025-07-11 | 0.24 |
| 2025-07-10 | 0.06 |
| 2025-07-09 | 0.10 |
| 2025-07-08 | 0.20 |
| 2025-07-07 | 0.30 |
| 2025-07-03 | 0.29 |
| 2025-07-02 | 0.33 |
| 2025-07-01 | 0.39 |
| 2025-06-30 | 0.36 |
| 2025-06-27 | 0.31 |
| 2025-06-26 | 0.38 |
| 2025-06-25 | 0.34 |
| 2025-06-24 | 0.18 |
| 2025-06-23 | 0.20 |
| 2025-06-20 | 0.08 |
| 2025-06-18 | 0.12 |
| 2025-06-17 | 0.02 |
| 2025-06-16 | -0.11 |
| 2025-06-13 | 0.02 |
| 2025-06-12 | -0.04 |
| 2025-06-11 | -0.06 |
| 2025-06-10 | -0.12 |
| 2025-06-09 | -0.17 |
| 2025-06-06 | -0.26 |
| 2025-06-05 | -0.09 |
| 2025-06-04 | -0.07 |
| 2025-06-03 | -0.10 |
| 2025-06-02 | -0.04 |
| 2025-05-30 | 0.06 |
| 2025-05-29 | 0.01 |
| 2025-05-28 | -0.01 |
| 2025-05-27 | 0.03 |
| 2025-05-23 | 0.18 |
| 2025-05-22 | 0.15 |
| 2025-05-21 | 0.14 |
| 2025-05-20 | 0.03 |
| 2025-05-19 | 0.12 |
| 2025-05-16 | 0.11 |
| 2025-05-15 | 0.19 |
| 2025-05-14 | -0.00 |
| 2025-05-13 | -0.09 |
| 2025-05-12 | -0.13 |
| 2025-05-09 | -0.09 |
| 2025-05-08 | -0.10 |
| 2025-05-07 | -0.11 |
| 2025-05-06 | -0.07 |
| 2025-05-05 | -0.31 |
| 2025-05-02 | -0.38 |
| 2025-05-01 | -0.37 |
| 2025-04-30 | -0.33 |